EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry with its Asian regional headquarters in Singapore and offices across Japan, China and other countries in the area, and Compai Pharma, an enterprising pharmaceutical company offering full-service commercialisation with offices in Singapore and Malaysia, today announced a strategic partnership to expand service across the Asia Pacific region.

Together, EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners to support full market implementation and development for life science and pharmaceutical companies ready to expand into these markets.

"As the needs of clients and their patients continue to grow, so too do our capabilities to scale delivery on a global level," said Jim Lang, CEO, EVERSANA. "The Asia Pacific region is one of the fastest-growing pharmaceutical markets in the world and requires regional expertise to increase patient access. Together with Compai Pharma, we're now able to drive greater value and services for our clients to support their evolving commercialisation needs." 

Capabilities available through the partnership include consulting, market access, medical awareness, education and communication, pharmacovigilance, marketing & sales excellence, as well as distribution and additional services.

"I am deeply honoured and excited to enter this partnership with such an esteemed company as EVERSANA," said Tim Cushway, Founder and Director at Compai Pharma. "Our mission is to work closely with healthcare practitioners across APAC to ensure needed medications and devices are available for patients while also becoming a trusted partner to provide education and updates on the latest in clinical developments. This goal is highly synergistic with EVERSANA's global ambition."